Amgen announces hold on Phase 1 obesity candidate, pipeline cutsnews2025-02-05T01:51:23+00:00February 5th, 2025|Endpoints News|
FDA approves Roche’s ocular implant in diabetic macular edemanews2025-02-04T20:41:27+00:00February 4th, 2025|Endpoints News|
Study using experimental Eli Lilly drug will try to stop Alzheimer’s decades before it beginsnews2025-02-04T14:00:24+00:00February 4th, 2025|Endpoints News|
Gene-edited pig kidneys will be tested in more humans soonnews2025-02-03T20:42:55+00:00February 3rd, 2025|Endpoints News|
Biogen’s research chief talks China, neuropsychiatry and pipeline plannews2025-02-03T18:45:35+00:00February 3rd, 2025|Endpoints News|
GH Research reports Phase 2b triumph for short-acting psychedelic drug in depressionnews2025-02-03T16:03:57+00:00February 3rd, 2025|Endpoints News|
Drugmakers seize on biomarkers to test the FDA’s rare disease shiftnews2025-02-03T15:52:29+00:00February 3rd, 2025|Endpoints News|
Algiax declares Phase 2 win for non-opioid drug for neuropathic painnews2025-02-03T15:00:35+00:00February 3rd, 2025|Endpoints News|
Daiichi Sankyo taps new CEO, aims to build up ADC franchisenews2025-01-31T16:01:16+00:00January 31st, 2025|Endpoints News|
Cargo Therapeutics cuts lead CAR-T program, 50% of staffnews2025-01-30T16:04:27+00:00January 30th, 2025|Endpoints News|
